Dilsizian V, Perrone-Filardi P, Arrighi J A, Bacharach S L, Quyyumi A A, Freedman N M, Bonow R O
Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.
Circulation. 1993 Sep;88(3):941-52. doi: 10.1161/01.cir.88.3.941.
Stress thallium scintigraphy provides important diagnostic and prognostic information in patients with coronary artery disease by demonstrating regional myocardial ischemia. However, if the clinical question being addressed is whether a region is viable and not whether there is inducible ischemia, then it may be more reasonable to perform rest-redistribution imaging rather than stress-redistribution imaging followed by either reinjection or late redistribution. Therefore, we determined whether stress-redistribution-reinjection and rest-redistribution imaging provide the same information regarding myocardial viability.
Both stress-redistribution-reinjection and rest-redistribution thallium single photon emission computed tomographic imaging was performed in 41 patients with chronic stable coronary artery disease, with quantitative analysis of regional thallium activity. Thallium reinjection was performed immediately after the 3- to 4-hour redistribution images were completed. Of the 155 myocardial regions with perfusion defects on the stress images, 91 (59%) were irreversible on conventional 3- to 4-hour redistribution images. When the outcomes of these irreversible regions were assessed after reinjection and compared with rest-redistribution images, there was concordance of data regarding myocardial viability (normal/reversible or irreversible) in 72 of the 91 (79%) irreversible defects. Twenty of the 41 patients also underwent positron emission tomography at rest with [18F]fluorodeoxyglucose and [15O]water. In these patients, stress-redistribution-reinjection and rest-redistribution imaging provided concordant information regarding myocardial viability in 427 (72%) of 594 myocardial regions and discordance in 167 regions. However, when irreversible thallium defects were further analyzed according to the severity of the thallium defect in these discordant regions, 149 of 167 (89%) demonstrated only mild-to-moderate reduction in thallium activity (51% to 85% of normal activity), and positron emission tomography verified 98% of these regions to be metabolically active and viable. Thus, when the severity of thallium activity was considered within irreversible thallium defects, the concordance between stress-redistribution-reinjection and rest-redistribution imaging regarding myocardial viability increased to 94%.
These data indicate that one of two imaging modalities, either stress-redistribution-reinjection or rest-redistribution imaging, may be used for identifying viable myocardium. However, if there are no contraindications to stress testing, stress-redistribution-reinjection imaging provides a more comprehensive assessment of the extent and severity of coronary artery disease by demonstrating regional myocardial ischemia without jeopardizing information on myocardial viability.
负荷铊闪烁扫描通过显示局部心肌缺血,为冠心病患者提供重要的诊断和预后信息。然而,如果所解决的临床问题是某一区域是否存活,而非是否存在诱发性缺血,那么进行静息-再分布显像可能比负荷-再分布显像随后进行再注射或延迟再分布更为合理。因此,我们确定负荷-再分布-再注射显像与静息-再分布显像在心肌存活方面是否提供相同信息。
对41例慢性稳定性冠心病患者进行了负荷-再分布-再注射和静息-再分布铊单光子发射计算机断层显像,并对局部铊活性进行定量分析。在3至4小时的再分布图像完成后立即进行铊再注射。在负荷图像上有灌注缺损的155个心肌区域中,91个(59%)在传统的3至4小时再分布图像上是不可逆的。当对这些不可逆区域在再注射后评估结果并与静息-再分布图像比较时,91个不可逆缺损中的72个(79%)在心肌存活(正常/可逆或不可逆)数据方面具有一致性。41例患者中的20例还进行了静息状态下的正电子发射断层显像,使用[18F]氟脱氧葡萄糖和[15O]水。在这些患者中,负荷-再分布-再注射显像与静息-再分布显像在594个心肌区域中的427个(72%)关于心肌存活提供了一致信息,在167个区域不一致。然而,当根据这些不一致区域中铊缺损的严重程度对不可逆铊缺损进一步分析时,167个中的149个(89%)仅显示铊活性轻度至中度降低(正常活性的51%至85%),正电子发射断层显像证实这些区域中有98%具有代谢活性且存活。因此,当在不可逆铊缺损中考虑铊活性的严重程度时,负荷-再分布-再注射显像与静息-再分布显像在心肌存活方面的一致性增加到94%。
这些数据表明,负荷-再分布-再注射显像或静息-再分布显像这两种显像方式中的一种可用于识别存活心肌。然而,如果负荷试验没有禁忌证,负荷-再分布-再注射显像通过显示局部心肌缺血,在不危及心肌存活信息的情况下,能更全面地评估冠状动脉疾病的范围和严重程度。